Kamau Therapeutics
kamau – Therapeutics
- Business Model
- B2B
- Website
- kamautx.com
- Last Round
- SeedDec 2023
- Rounds
- 1
About
Clinical-stage gene correction company developing therapies using high-efficiency targeted gene integration.
Summary
Kamau Therapeutics is a Biotech company. Its most recent funding was a Seed round in Dec 2023. Investors include Draper Associates and Khosla Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company